Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash from Operations (2024 - 2025)

Historic Cash from Operations for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to -$13.3 million.

  • Pyxis Oncology's Cash from Operations rose 946.47% to -$13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.4 million, marking a year-over-year change of. This contributed to the annual value of -$57.7 million for FY2024, which is 1843.75% up from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Cash from Operations is -$13.3 million, which was up 946.47% from -$17.3 million recorded in Q2 2025.
  • Pyxis Oncology's 5-year Cash from Operations high stood at -$3.0 million for Q2 2024, and its period low was -$22.5 million during Q1 2025.